|
Spencer B Barfuss1, Dongngan T Truong1, Karen E James2, Christi J Inman2, S Adil Husain3, Richard V Williams1, L LuAnn Minich1, Christopher R Mart1
1 Department of Pediatrics, Division of Cardiology, University of Utah/Primary Children's Hospital, Utah, USA
2 Department of Pediatrics, Division of Rheumatology, University of Utah/Primary Children's Hospital, Utah, USA
3 Department of Surgery, Division of Cardiothoracic Surgery, University of Utah/Primary Children's Hospital, Utah, USA
Correspondence Address:
Dr. Spencer B Barfuss
81 N. Mario Capecchi Drive, Salt Lake City, Utah, 84113
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/apc.apc_82_21
A 3-year-old girl presenting with fever, mucocutaneous inflammation, and acute gastrointestinal symptoms met criteria for the multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C). Echocardiography showed severely decreased left ventricular (LV) function with an apical mass. After treatment with intravenous (IV) immunoglobulin, IV steroids, anakinra, milrinone, and systemic anticoagulation, her LV function rapidly improved and the mass became increasingly mobile. Given the risk of systemic embolization, the mass was excised through left ventriculotomy and pathology confirmed a thrombus.
[FULL TEXT] [PDF]*
|
Search Pubmed for
